Natasha Olsson

Neobiomics AB and ExCEEd Orphan s.r.o. announce exclusive cooperation for Central and Eastern Europe

Press Release in PDF format.Stockholm, Sweden, 21 May, 2021 – Neobiomics AB and ExCEEd Orphan s.r.o. have entered an exclusive distribution agreement valid for 14 countries in Central and Eastern Europe (CEE). The agreement includes marketing and sales of Neobiomics’ proprietary product ProPrems® and is in effect immediately.  Neobiomics is a Sweden-based company specialized in the… Read More »Neobiomics AB and ExCEEd Orphan s.r.o. announce exclusive cooperation for Central and Eastern Europe

Neobiomics AB and Ewopharma AG announce an exclusive collaboration for distribution of ProPrems® in Switzerland

Press-Release as PDF. Stockholm, Sweden, 17 May, 2021 – Neobiomics AB and Ewopharma AG have entered an exclusive distribution agreement valid for the territory of Switzerland. The agreement includes marketing and sales of Neobiomics’ proprietary product ProPrems® and is in effect immediately. Neobiomics AB is… Read More »Neobiomics AB and Ewopharma AG announce an exclusive collaboration for distribution of ProPrems® in Switzerland

Mårten Österlund appointed as new Chairman for Neobiomics Board of Directors

Wednesday, April 28th 2021, Neobiomics held its Annual General Meeting. For Mårten Österlund’s extensive knowledge from R&D and the pharmaceutical market, and with documented experience in successful launches of innovative products, Mårten Österlund was elected to the Neobiomics Board of Directors, in which he was also appointed Chairman. Ann-Charlotte Beckman, Kristina Magnusson Borg,… Read More »Mårten Österlund appointed as new Chairman for Neobiomics Board of Directors